0001209191-13-048483.txt : 20131016 0001209191-13-048483.hdr.sgml : 20131016 20131016162135 ACCESSION NUMBER: 0001209191-13-048483 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131014 FILED AS OF DATE: 20131016 DATE AS OF CHANGE: 20131016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6173416100 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Silva Paul M CENTRAL INDEX KEY: 0001446372 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 131154426 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-10-14 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001446372 Silva Paul M C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST. CAMBRIDGE MA 02139 0 1 0 0 SVP & Corp Controller Common Stock 2013-10-14 4 M 0 468 33.82 A 12218 D Common Stock 2013-10-14 4 M 0 1125 51.75 A 13343 D Common Stock 2013-10-14 4 S 0 214 70.41 D 13129 D Common Stock 2013-10-14 4 S 0 500 71.57 D 12629 D Common Stock 2013-10-14 4 S 0 754 72.26 D 11875 D Common Stock 2013-10-14 4 S 0 125 73.22 D 11750 D Common Stock 169 I 401(k) Stock Option (right to buy) 33.82 2013-10-14 4 M 0 468 0.00 D 2020-07-13 Common Stock 468 1407 D Stock Option (right to buy) 51.75 2013-10-14 4 M 0 1125 0.00 D 2021-07-12 Common Stock 1125 7875 D Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $70.41 (range $70.00 to $70.85). Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $71.57 (range $71.00 to $71.93). Open market sales reported on this line occurred at a weighted average price of $72.26 (range $72.01 to $72.89). The option vests in 16 quarterly installments from 07/14/2010. The option vests in 16 quarterly installments from 07/13/2011. Kenneth L. Horton, Attorney-In-Fact 2013-10-16